Posted on 9/24/18
Cognizant Board Elects Michael Patsalos-Fox as Chairman
Cognizant (Nasdaq: CTSH) today announced that its Board of Directors has elected Board member Michael Patsalos-Fox as its new Chairman.
Posted on 9/24/18
Michael Houghton Appointed To Artesian Resources Board of Directors
Artesian Resources Corporation (Nasdaq: ARTNA), which includes operations in Delaware, Maryland and Pennsylvania, today announced the expansion of the Board of Directors
Posted on 9/23/18
ORBCOMM Elects Denise Gibson to Its Board of Directors
ORBCOMM Inc. (Nasdaq: ORBC), a global provider of Machine-to-Machine (M2M) and Internet of Things (IoT) solutions
Posted on 9/20/18
Dr. Paul Karpecki Named Lead Optometric Advisor
MULLICA HILL, N.J.--(BUSINESS WIRE)--OcuMedic, Inc., the developer of new, drug-eluting soft contact lens and clear corneal bandage technology, today announced the appointment of Paul Karpecki, OD, . . .
Posted on 9/19/18
Clark Capital Management Group Adds Larry Roth to Board of Directors
Clark Capital Management Group, an independent asset manager founded in 1986, announced today the appointment of
Posted on 9/18/18
Idera Pharmaceuticals Appoints Howard Pien to its Board of Directors
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary
Posted on 9/18/18
Former Inogen CEO, Ray Huggenberger, Joins Ebb Therapeutics Board of Directors
Ebb Therapeutics, a med-tech start-up that develops innovative products designed to help the millions of insomnia sufferers, announces that its added Ray Huggenberger
Posted on 9/18/18
Paul Simms to Join Hu-manity.co Advisory Board
Hu-manity.co, the company behind the 31st Human Right making your data your property, announces Paul Simms, the chair of eyeforpharma, will join as an advisory board . . .
Posted on 9/17/18
Myers Industries Appoints Lori Lutey to Its Board of Directors
Myers Industries, Inc. (NYSE: MYE) today announced that Lori Lutey, retired Executive Vice President and Chief Financial Officer of Schneider National (NYSE: SNDR)
Posted on 9/14/18
Risk Management Association Announces New Board Leaders
Edward P. Schreiber, executive vice president and chief risk officer, Zions Bancorporation, Salt Lake City, Utah, was elected chair
Posted on 9/13/18
Real Endpoints Appoints Jeff Berkowitz, CEO and Director
Real Endpoints (RE), a leader in the development and implementation of proprietary tools to strengthen pharmaceutical market access
Posted on 9/12/18
United States Hispanic Chamber of Commerce Announces Additions to Board of Directors
Washington, DC, Sept. 12, 2018 (GLOBE NEWSWIRE) -- The United States Hispanic Chamber of Commerce (USHCC) is proud to announce the addition of six new members . . .
Posted on 9/12/18
Prudential Financial Appoints Charles Lowrey as CEO
Prudential Financial, Inc. (NYSE:PRU) today announced that its Board of Directors has appointed Charles Lowrey as the company’s next CEO and member of the Board
Posted on 9/12/18
Cyclacel Pharmaceuticals Appoints Robert J. Spiegel, M.D. to Board of Directors
Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP), a biopharmaceutical company developing innovative medicines based on cancer biology
Posted on 9/12/18
iconectiv Elects John Curreri as Chair
BRIDGEWATER, N.J.--(BUSINESS WIRE)--iconectiv, a partner of the global communications industry connecting more than two billion people every day, has taken over the leadership of the Automatic . . .
Posted on 9/12/18
Ocean Power Technologies Appoints Kristine S. Moore to Board
Ocean Power Technologies (Nasdaq: OPTT), a leader in innovative and cost-effective ocean energy solutions today announced that Kristine S. Moore
Posted on 9/11/18
Koppers Expands Board with Election of New Directors
Koppers Holdings Inc. (NYSE: KOP) today announced that it has increased the size of its Board of Directors from eight to 11 directors and as part . . .
Posted on 9/11/18
Amicus Therapeutics Appoints Lynn D. Bleil To Board; Michael G. Raab Named Lead Independent Director
Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases
Posted on 9/11/18
Idera Pharmaceuticals Appoints Bryant D. Lim as Senior Vice President, General Counsel and Secretary of the Board of Directors
EXTON, Pa., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune . . .
Posted on 9/7/18
VISIT PHILADELPHIA Names Jeff Guaracino CEO
The Board of Directors of VISIT PHILADELPHIA® today announced that following an extensive national search, Jeff Guaracino, current president and CEO of Welcome America, Inc., has . . .
Posted on 9/7/18
Matinas BioPharma Appoints Patrick G. LePore to Board of Directors
Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling targeted intracellular
Posted on 9/5/18
Palvella Therapeutics Appoints Elaine J. Heron, PhD to Board of Directors
Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically targeted therapies for debilitating
Posted on 9/5/18
Provention Bio Appoints Accomplished Biotech Executive, Chip Catlin, to its Board of Directors
Provention Bio, Inc. (Nasdaq:PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced today the appointment of Avery (Chip) W. Catlin, a . . .
Posted on 9/5/18
Marinus Appoints Scott Braunstein, MD to its Board of Directors
Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy
Posted on 9/5/18
Michael Baker International CEO Brian A. Lutes Appointed to Leadership Pittsburgh Inc.'s Board of Directors
Michael Baker International, a global leader in engineering, planning and consulting services, today announced that Brian A. Lutes, the firm's President and Chief Executive
Philadelphia
